Elytron Biotech

Elytron Biotech is an Argentine biotechnology company that leverages artificial intelligence to transform the research and development process for biological products. By utilizing its proprietary AI-driven platform, known as SEE, the company digitizes and maps large-scale banks of microorganisms and their derivatives. This technological approach allows Elytron to screen and characterize strains with greater efficiency, predicting their potential for applications in agriculture and other bio-based industries while significantly reducing the risks and costs associated with industrialization and empirical validation.

For industry partners, Elytron provides solutions that streamline biological product pipelines, helping to accelerate the market launch of new biocontrol, biostimulation, and bionutrition inputs. By integrating their platform into existing R&D processes, clients can maximize their investment value, discover novel modes of action for their products, and identify synergies to improve portfolio performance. Headquartered in Buenos Aires, the company works to shift industry standards from linear, time-intensive methods to data-driven digital processes, ultimately aiming to deliver robust and high-performance biological innovations.